ResMed (RMD)
(Delayed Data from NYSE)
$218.06 USD
+34.64 (18.89%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $218.00 -0.06 (-0.03%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for ResMed Inc falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 897.56 | 779.44 | 474.51 | 621.67 | 404.59 |
Depreciation/Amortization & Depletion | 197.56 | 193.84 | 191.52 | 181.37 | 150.80 |
Net Change from Assets/Liabilities | -462.13 | -708.08 | 1.40 | -97.92 | -177.05 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 60.31 | 85.95 | 69.29 | 97.13 | 80.72 |
Net Cash From Operating Activities | 693.30 | 351.15 | 736.72 | 802.26 | 459.05 |
Property & Equipment | -119.67 | -134.84 | -102.71 | -95.33 | -68.71 |
Acquisition/ Disposition of Subsidiaries | -1,012.75 | -42.78 | -39.07 | -27.91 | -951.38 |
Investments | -28.29 | -13.92 | -21.79 | -31.62 | -46.72 |
Other Investing Activities | 0.87 | -38.38 | 5.11 | -25.01 | -8.90 |
Net Cash from Investing Activities | -1,159.85 | -229.92 | -158.46 | -179.86 | -1,075.71 |
Uses of Funds
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 49.14 | 47.38 | 37.79 | 48.18 | 13.88 |
Issuance (Repayment) of Debt | 665.00 | 122.00 | -522.00 | -94.01 | 807.49 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -258.28 | -245.34 | -226.71 | -225.09 | -211.71 |
Other Financing Activities | -32.99 | -52.41 | -53.71 | -46.36 | -29.01 |
Net Cash from Financing Activities | 422.87 | -128.36 | -764.63 | -317.29 | 580.64 |
Effect of Exchange Rate Changes | -2.15 | -14.43 | 18.50 | 10.92 | -5.56 |
Net Change In Cash & Equivalents | -45.82 | -21.57 | -167.88 | 316.03 | -41.57 |
Cash at Beginning of Period | 273.71 | 295.28 | 463.16 | 147.13 | 188.70 |
Cash at End of Period | 227.89 | 273.71 | 295.28 | 463.16 | 147.13 |
Diluted Net EPS | 6.09 | 5.30 | 3.24 | 4.27 | 2.80 |
Fiscal Year End for ResMed Inc falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 428.22 | 219.42 | 897.56 | 667.89 |
Depreciation/Amortization & Depletion | NA | 106.81 | 53.44 | 197.56 | 142.36 |
Net Change from Assets/Liabilities | NA | -53.15 | -9.59 | -462.13 | -399.14 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 77.24 | 23.01 | 60.31 | 44.75 |
Net Cash From Operating Activities | NA | 559.12 | 286.28 | 693.30 | 455.86 |
Property & Equipment | NA | -53.39 | -30.04 | -119.67 | -85.22 |
Acquisition/ Disposition of Subsidiaries | NA | -110.69 | -103.18 | -1,012.75 | -1,011.23 |
Investments | NA | -7.06 | -3.43 | -28.29 | -25.79 |
Other Investing Activities | NA | -18.99 | -12.33 | 0.87 | 8.92 |
Net Cash from Investing Activities | NA | -190.12 | -148.98 | -1,159.85 | -1,113.32 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -29.50 | 0.98 | 49.14 | 25.65 |
Issuance (Repayment) of Debt | NA | -210.00 | -80.00 | 665.00 | 810.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | -141.28 | -70.60 | -258.28 | -193.57 |
Other Financing Activities | NA | -9.32 | -1.52 | -32.99 | -30.61 |
Net Cash from Financing Activities | NA | -390.09 | -151.13 | 422.87 | 611.47 |
Effect of Exchange Rate Changes | NA | 3.45 | -4.96 | -2.15 | 0.18 |
Net Change In Cash & Equivalents | NA | -17.64 | -18.79 | -45.82 | -45.82 |
Cash at Beginning of Period | NA | 227.89 | 227.89 | 273.71 | 273.71 |
Cash at End of Period | NA | 210.25 | 209.10 | 227.89 | 227.89 |
Diluted Net EPS | NA | 1.42 | 1.49 | 1.55 | 1.58 |